Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Reacx Pharms Drug Patent Portfolio

Reacx Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Reacx Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7736665 Implantable polymeric device for sustained release of buprenorphine 25 Apr, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Reacx Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Yr, Small Entity 01 Dec, 2021 US7736665
Email Notification
Critical
24 Aug, 2018 US7736665
Change in Power of Attorney (May Include Associate POA)
Critical
22 Aug, 2018 US7736665
Correspondence Address Change
Critical
21 Aug, 2018 US7736665
Payment of Maintenance Fee, 8th Yr, Small Entity 13 Nov, 2017 US7736665
Post Issue Communication - Certificate of Correction 09 Mar, 2017 US7736665
Post Issue Communication - Certificate of Correction 07 Mar, 2017 US7736665
Email Notification
Critical
09 Jan, 2015 US7736665
Change in Power of Attorney (May Include Associate POA)
Critical
09 Jan, 2015 US7736665
Correspondence Address Change
Critical
08 Jan, 2015 US7736665
Change in Power of Attorney (May Include Associate POA)
Critical
07 Oct, 2014 US7736665
Email Notification
Critical
07 Oct, 2014 US7736665
Correspondence Address Change
Critical
06 Oct, 2014 US7736665
Patent Issue Date Used in PTA Calculation
Critical
15 Jun, 2010 US7736665
Recordation of Patent Grant Mailed
Critical
15 Jun, 2010 US7736665


Reacx Pharms's Family Patents

Reacx Pharms drugs have patent protection in a total of 13 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Reacx Pharms Drug List

Given below is the complete list of Reacx Pharms's drugs and the patents protecting them.


1. Probuphine

Probuphine is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7736665 Implantable polymeric device for sustained release of buprenorphine 25 Apr, 2024
(7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Probuphine's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List